Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma

Podobne knjige/članki

• Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
  od: LoRusso, Patricia M., et al.
  Izdano: (2011)
• Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
  od: Z. A.-G. Radzhabova, et al.
  Izdano: (2020-02-01)
• Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
  od: Z. A.-G. Radzhabova, et al.
  Izdano: (2020-02-01)
• The dawn of hedgehog inhibitors: Vismodegib
  od: Sandhiya, Selvarajan, et al.
  Izdano: (2013)
• Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
  od: Graham, Richard A., et al.
  Izdano: (2011)